We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
As with all products, we will keep its safety under close review
As with all products, the MHRA will keep its safety under close review.
Mental health apps are everywhere, offering everything from mood tracking to therapy. But with so many options, how can people tell what these tools actually do?
As with all medicines, the MHRA will continue to monitor the safety and effectiveness of Trixeo Aerosphere
The Medicines and Healthcare products Regulatory Agency (MHRA) has today (1 May 2025) approved a vaccine (Vimkunya) used to prevent disease caused by the chikungunya virus in people 12 years of age and older.
Dawn raids in four counties across the West Midlands and the Northwest of England this morning (29 April) dismantle major criminal network trafficking unlicensed medicines.
The Medicines and Healthcare products Regulatory Agency (MHRA) is reminding patients with asthma of the importance of using their preventer (anti-inflammatory) inhaler regularly as prescribed, and to avoid relying on their b…
As with all products, we will keep its safety under close review.
Patients who take the common blood pressure medicine Lercanidipine HCI 20mg tablets (lercanidipine hydrochloride) from the manufacturer Recordati Pharmaceuticals Limited, should, as a precautionary measure, urgently check if…
The appointment will involve a time commitment of 22 days per year. Remuneration for the role will be at a rate of £325 per attendance and preparation for meetings.
12-month roll-out begins today for the biggest regulatory shake up of clinical trials in 20 years
New analysis of the current clinical trial landscape in the UK shows clear opportunities to shape the future of medical research and patient care.
The World Health Organization (WHO) has confirmed the successful redesignation of the Medicines and Healthcare products Regulatory Agency (MHRA)’s Science and Research group as one of its Collaborating Centres for the Standa…
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab and requires JavaScript).